HMC Capital to acquire Healthscope-operated private hospitals for $802m

By NS Healthcare Staff Writer

30 Mar 23

HMC Capital, through its affiliate HealthCo Healthcare & Wellness REIT, will buy a portfolio of 11 private hospitals…

Patient CareClinical Care

Eris Lifesciences to acquire dermatology brands from Dr Reddy’s for $33m

By NS Healthcare Staff Writer

17 Mar 23

The dermatology brands sold by Dr. Reddy's to Eris Lifesciences include Hydroheal, Revilus, Avarta, Aquaderm, and others

Patient CarePharmaceuticals and Medicines

Pfizer to acquire American biotech company Seagen for $43bn

By NS Healthcare Staff Writer

14 Mar 23

The deal is expected to allow for combining potential across the pipelines of both firms and will make…

Patient CarePharmaceuticals and Medicines

Dr. Reddy’s to buy Mayne Pharma’s US generic prescription product portfolio

By NS Healthcare Staff Writer

28 Feb 23

Mayne’s portfolio to be acquired comprises around 45 commercial products, four pipeline products and 40 regulatory-approved non-marketed products,…

Patient CarePharmaceuticals and Medicines

Pfizer in early-stage talks to acquire cancer drugmaker Seagen

By NS Healthcare Staff Writer

28 Feb 23

Seagen has developed drugs like Adcetris, Tivdak, and Padcev based on its proprietary ADC technology

Patient CarePharmaceuticals and Medicines

CVS Health to acquire US healthcare company Oak Street Health for $10.6bn

By NS Healthcare Staff Writer

09 Feb 23

Upon closing of the transaction, Oak Street Health will become part of CVS Health's recently established Health Care…

Patient CareClinical Care

Sandoz to acquire antifungal agent Mycamine from Astellas

By NS Healthcare Staff Writer

24 Jan 23

The addition of Mycamine is expected to considerably strengthen Sandoz’s hospital offering, anti-infective portfolio, and a global programme…

Patient CarePharmaceuticals and Medicines

Sun Pharma to buy US-based Concert Pharmaceuticals for $576m

By NS Healthcare Staff Writer

20 Jan 23

Concert Pharmaceuticals’ deuruxolitinib is an oral inhibitor of Janus kinases JAK1 and JAK2, which is currently in late-stage…

Patient CarePharmaceuticals and Medicines

Chiesi Farmaceutici to acquire Amryt Pharma for up to $1.48bn

By NS Healthcare Staff Writer

09 Jan 23

Amryt Pharma is a commercial-stage biopharmaceutical firm that acquires, develops and commercialises treatments to help improve the lives…

Patient CarePharmaceuticals and Medicines

Blacksmith, Forge to merge for developing metalloenzymes-targeting drugs

By NS Healthcare Staff Writer

03 Jan 23

Under the deal, both firms will use their combined chemistry platforms to create a biopharma that will develop…

Patient CarePharmaceuticals and Medicines